Jooho P Kim1, Peter J Kahrilas2. 1. Feinberg School of Medicine, Department of Medicine, Northwestern University, 676 St Clair St, 14th floor, Chicago, IL, 60611-2951, USA. 2. Feinberg School of Medicine, Department of Medicine, Northwestern University, 676 St Clair St, 14th floor, Chicago, IL, 60611-2951, USA. p-kahrilas@northwestern.edu.
Abstract
PURPOSE OF REVIEW: This review presents an overview of the diagnostic approach to esophageal dysphagia and summarizes recent epidemiological trends and technical advancements. RECENT FINDINGS: The evaluation of dysphagia begins with a detailed history followed by endoscopy to evaluate for any structural abnormalities including malignancy. This is especially true given the emergence of eosinophilic esophagitis (EoE) as a dominant cause of esophageal dysphagia. In fact, it is now standard practice to obtain esophageal biopsies during endoscopy performed to evaluate dysphagia, since EoE can present without the characteristic mucosal features of rings, furrows, and exudate. Achalasia is also more frequently encountered since the introduction of high-resolution manometry (HRM) and the Chicago Classification into clinical practice. The Chicago Classification provides a stepwise diagnostic algorithm for evaluating HRM studies and systematically diagnosing esophageal motility disorders. Lastly, the functional lumen imaging probe (FLIP) is a novel technology that has added insight into both achalasia and EoE. Measuring esophageal distensibility with FLIP has useful prognostic implications for both diseases, and FLIP can identify motility abnormalities in achalasics not detected with HRM. A careful history is key to the efficient evaluation of dysphagia, and endoscopy is usually the first diagnostic study to obtain. For patients with prominent reflux symptoms, an empiric trial with proton pump inhibitors is reasonable then because reflux disease is such a common cause of dysphagia. Thereafter, patients should undergo HRM to evaluate for a motility disorder, and FLIP can provide complementary data to guide management.
PURPOSE OF REVIEW: This review presents an overview of the diagnostic approach to esophageal dysphagia and summarizes recent epidemiological trends and technical advancements. RECENT FINDINGS: The evaluation of dysphagia begins with a detailed history followed by endoscopy to evaluate for any structural abnormalities including malignancy. This is especially true given the emergence of eosinophilic esophagitis (EoE) as a dominant cause of esophageal dysphagia. In fact, it is now standard practice to obtain esophageal biopsies during endoscopy performed to evaluate dysphagia, since EoE can present without the characteristic mucosal features of rings, furrows, and exudate. Achalasia is also more frequently encountered since the introduction of high-resolution manometry (HRM) and the Chicago Classification into clinical practice. The Chicago Classification provides a stepwise diagnostic algorithm for evaluating HRM studies and systematically diagnosing esophageal motility disorders. Lastly, the functional lumen imaging probe (FLIP) is a novel technology that has added insight into both achalasia and EoE. Measuring esophageal distensibility with FLIP has useful prognostic implications for both diseases, and FLIP can identify motility abnormalities in achalasics not detected with HRM. A careful history is key to the efficient evaluation of dysphagia, and endoscopy is usually the first diagnostic study to obtain. For patients with prominent reflux symptoms, an empiric trial with proton pump inhibitors is reasonable then because reflux disease is such a common cause of dysphagia. Thereafter, patients should undergo HRM to evaluate for a motility disorder, and FLIP can provide complementary data to guide management.
Authors: Peter J Kahrilas; Albert J Bredenoord; Dustin A Carlson; John E Pandolfino Journal: Clin Gastroenterol Hepatol Date: 2018-04-24 Impact factor: 11.382
Authors: C P Gyawali; S Roman; A J Bredenoord; M Fox; J Keller; J E Pandolfino; D Sifrim; R Tatum; R Yadlapati; E Savarino Journal: Neurogastroenterol Motil Date: 2017-05-24 Impact factor: 3.598
Authors: Saowanee Ngamruengphong; Burkhard H A von Rahden; Jörg Filser; Amy Tyberg; Amit Desai; Reem Z Sharaiha; Arnon Lambroza; Vivek Kumbhari; Mohamad El Zein; Ahmed Abdelgelil; Sepideh Besharati; John O Clarke; Ellen M Stein; Anthony N Kalloo; Michel Kahaleh; Mouen A Khashab Journal: Surg Endosc Date: 2015-10-20 Impact factor: 4.584
Authors: Salih Samo; Dustin A Carlson; Dyanna L Gregory; Susan H Gawel; John E Pandolfino; Peter J Kahrilas Journal: Clin Gastroenterol Hepatol Date: 2016-08-28 Impact factor: 11.382
Authors: P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino Journal: Neurogastroenterol Motil Date: 2014-12-03 Impact factor: 3.598
Authors: J E Pandolfino; E Leslie; D Luger; B Mitchell; M A Kwiatek; P J Kahrilas Journal: Neurogastroenterol Motil Date: 2009-12-27 Impact factor: 3.598
Authors: In Kyung Yoo; Sang Ah Choi; Won Hee Kim; Sung Pyo Hong; Ozlem Ozer Cakir; Joo Young Cho Journal: Gut Liver Date: 2019-01-15 Impact factor: 4.519